Hello, everyone, and how are you today? We are just fine, thank you, now that the Pharmalot campus has settled down. The short person successfully left for the local schoolhouse for another day of learning and the official mascots are happily snoozing in their respective corners. As for us, we are leafing through documents, scheduling calls, and, in general, foraging for interesting items. Speaking of which, here are a few to help you along on your own journey. Hope all goes well and do drop us a line when you hear something fascinating …

A Philippine government agency filed a lawsuit against Sanofi (SNY) demanding $81,600 in compensation for the parents of a 10-year-old girl who the agency claims had died as a result of receiving its dengue vaccine, Channel NewsAsia says. The Public Attorney’s Office maintains the girl should not have been vaccinated because a forensic examination showed she had a pre-existing disease, but the drug maker counters that it does not know of any deaths resulting from the vaccine, which can raise the risk of severe disease in people who were not exposed to the virus. Sanofi did agree to reimburse the Philippines $29 million for the cost of unused vaccine and conduct serotesting of the roughly 830,000 children who were vaccinated.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy